Stuart H. Orkin, MD, an investigator of the Howard Hughes Medical Institute at Boston Children’s Hospital and Dana-Farber Cancer Institute and a professor at Harvard Medical School, is the recipient of the 2018 Mechthild Esser Nemmers Prize in Medical Science at Northwestern University.
On May 6, the Illinois Precision Medicine Consortium hosted a launch event at Chicago’s Millennium Park, one of many simultaneous events held around the country to mark the program’s launch.
NewCures at Northwestern University is a novel accelerator working to identify promising potential therapies in development, fund research into their viability, and promote their development as new drugs.
Mutations in a gene called DBR1 may increase patients’ susceptibility to brain infection, according to a study published in Cell.
A study, published in Proceedings of the National Academy of Sciences, provides new insights into the organization of a key protein called cadherin within structures called adherens junctions, which help cells stick together.
Scientists discovered the regulatory role of the enzyme CDK5 in an aggressive form of brain cancer and successfully halted tumor growth by inhibiting it.
Northwestern scientists restored chemical balance to certain brain cells in mouse models, reversing mechanisms that may be responsible for sensory hypersensitivity in patients with autism.
Third-year medical student Ben Peipert co-founded Second Opinions, a student-run pro-bono consulting group, and brings his consulting skills to his research on quality of life in endocrine disorders.
Within the Institute for Public Health and Medicine (IPHAM), investigators collaborate at the intersection of public health and medicine — connecting clinics to communities and accelerating innovations that impact the health of both patients and populations.
The addition of a chemotherapy drug to adjuvant hormone therapy did not improve survival for patients with high-risk prostate cancer, according to a new study.
